Press Releases Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-22 pm EDT			5-day change	1st Jan Change
1.74 ^USD	+5.45%		-2.79%	0.00%

Mar. 11	Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street	MT
Mar. 11	Top Premarket Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target	May. 21	AQ
Sonnet BioTherapeutics : Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target - Form 8-K	May. 20	PU
Sonnet BioTherapeutics Announces Participation in the EF Hutton Annual Global Conference	May. 03	NE
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy at the AACR 2024 Annual Meeting	Mar. 20	AQ
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy Volunteers	Mar. 01	AQ
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update	Feb. 15	AQ
Sonnet BioTherapeutics Announces Publication Demonstrating Suitability of SON-1210, the First Albumin-binding Bifunctional IL-12/IL-15 Fusion Protein, for Solid Tumor Immunotherapy	Dec. 22	AQ
Sonnet BioTherapeutics Provides Fiscal Year 2023 Business and Financial Update	Dec. 15	AQ
Sonnet BioTherapeutics Announces Pricing of $4.55 Million Underwritten Public Offering	23-10-26	AQ
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation by a Key Opinion Leader at the 2023 Connective Tissue Oncology Society Annual Meeting	23-10-18	AQ
Sonnet BioTherapeutics Announces Results of Biodistribution Studies Demonstrating Solid Tumor Targeting Using the FHAB Technology	23-09-21	AQ
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance	23-09-20	AQ
Sonnet BioTherapeutics : Modification to Rights of Security Holders - Form 8-K	23-09-01	PU
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split	23-09-01	AQ
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update	23-08-15	AQ
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference	23-08-01	AQ
Sonnet BioTherapeutics : Shareholder Director Nominations - Form 8-K	23-07-21	PU
Traders Insights: These Biotech Stocks On Radar: VSTM, SNTX, CGEN, SONN	23-06-06	AQ
SONNET BIOTHERAPEUTICS HOLDINGS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-10	AQ
SONNET BIOTHERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Press Releases

Filters